Newleos Therapeutics, Inc. is a pioneering clinical-stage neuroscience company focused on the innovation of therapies for neuropsychiatric disorders. With a commitment to addressing the pressing unmet needs in mental health, Newleos is dedicated to developing effective tools for anxiety and substance use disorders, impacting millions across the United States.
Company Values
Newleos stands out for its focus on first-in-class therapies that target novel mechanisms, aiming to reduce side effects compared to current treatment options.